Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2677 |
|
| Actual shortage: | 256 (10%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2412 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
24 (9%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-LISINOPRIL/HCTZ (TYPE Z) | 12.5MG 20MG | TABLET | Resolved | 2023-06-08 | 2023-07-06 | 194119 |
| TEVA-LISINOPRIL/HCTZ (TYPE Z) | 25MG 20MG | TABLET | Resolved | 2023-06-08 | 2023-06-27 | 194122 |
| TEVA-LISINOPRIL/HCTZ (TYPE Z) | 12.5MG 20MG | TABLET | Resolved | 2023-06-16 | 2023-08-04 | 195033 |
| TEVA-LISINOPRIL/HCTZ (TYPE Z) | 25MG 20MG | TABLET | Resolved | 2023-06-16 | 2023-06-27 | 195124 |
| TEVA-LISINOPRIL/HCTZ (TYPE Z) | 25MG 20MG | TABLET | Resolved | 2023-06-16 | 2023-06-27 | 195204 |
| TEVA-LISINOPRIL/HCTZ (TYPE Z) | 12.5MG 20MG | TABLET | Resolved | 2023-06-19 | 2023-07-14 | 195597 |
| TEVA-LISINOPRIL/HCTZ (TYPE Z) | 25MG 20MG | TABLET | Resolved | 2023-07-04 | 2023-08-04 | 197104 |
| TEVA-LISINOPRIL/HCTZ (TYPE Z) | 12.5MG 10MG | TABLET | Resolved | 2023-07-18 | 2023-10-03 | 199103 |
| TEVA-LISINOPRIL/HCTZ (TYPE Z) | 25MG 20MG | TABLET | Resolved | 2023-08-17 | 2023-10-04 | 202278 |
| TEVA-LISINOPRIL (TYPE Z) | 20MG | TABLET | Resolved | 2020-07-16 | 2020-09-17 | 120491 |
| TEVA-LISINOPRIL (TYPE Z) | 10MG | TABLET | Resolved | 2020-10-01 | 2020-11-07 | 125464 |
| TEVA-LISINOPRIL (TYPE Z) | 10MG | TABLET | Resolved | 2020-12-17 | 2021-02-05 | 130304 |
| TEVA-LISINOPRIL (TYPE Z) | 20MG | TABLET | Resolved | 2020-12-17 | 2021-02-05 | 130310 |
| TEVA-LISINOPRIL (TYPE Z) | 5MG | TABLET | Resolved | 2020-12-17 | 2021-07-09 | 130316 |
| TEVA-LISINOPRIL (TYPE Z) | 5MG | TABLET | Resolved | 2021-01-15 | 2021-02-05 | 131697 |
| TEVA-LISINOPRIL (TYPE Z) | 20MG | TABLET | Resolved | 2021-03-04 | 2021-04-21 | 135123 |
| TEVA-LISINOPRIL (TYPE Z) | 5MG | TABLET | Resolved | 2021-03-11 | 2021-04-21 | 135564 |
| TEVA-LISINOPRIL (TYPE Z) | 10MG | TABLET | Resolved | 2021-03-18 | 2021-08-13 | 135968 |
| TEVA-LISINOPRIL (TYPE Z) | 10MG | TABLET | Resolved | 2023-04-27 | 2023-06-09 | 190692 |
| TEVA-LISINOPRIL (TYPE P) | 20MG | TABLET | Resolved | 2017-03-14 | 2017-07-27 | 2310 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACT DILTIAZEM CD | 120MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2019-04-11 | 2019-04-11 | 81381 |
| ACT DILTIAZEM CD | 180MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2019-04-11 | 2019-04-11 | 81418 |
| ACT DILTIAZEM CD | 120MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2021-07-22 | 2021-07-22 | 142915 |
| ACT DILTIAZEM CD | 300MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2021-07-22 | 2021-07-22 | 142918 |
| ACT DILTIAZEM CD | 180MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2021-07-22 | 2021-07-22 | 142921 |
| ACT CLOPIDOGREL | Discontinued | 2018-10-19 | 2018-10-19 | 65065 | ||
| ACT CELECOXIB | 100MG | CAPSULE | To be discontinued | 2020-09-03 | 2020-09-03 | 123648 |
| ACT CELECOXIB | 200MG | CAPSULE | To be discontinued | 2020-09-03 | 2020-09-03 | 123651 |
| ACT CELECOXIB | 200MG | CAPSULE | Discontinued | 2021-02-12 | 2021-02-12 | 133874 |
| ACT CELECOXIB | 100MG | CAPSULE | Discontinued | 2021-02-12 | 2021-02-12 | 133880 |